- Forums
- ASX - By Stock
- FDA Approval
Another week. And no approval.
-
- There are more pages in this discussion • 296 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
|
|||||
Last
$6.76 |
Change
-0.040(0.59%) |
Mkt cap ! $4.843B |
Open | High | Low | Value | Volume |
$6.79 | $6.81 | $6.68 | $6.362M | 942.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 23 | $7.26 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.09 | 5146 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 23 | 7.260 |
3 | 10065 | 7.100 |
10 | 55416 | 7.090 |
2 | 1366 | 7.010 |
8 | 47807 | 6.960 |
Price($) | Vol. | No. |
---|---|---|
6.090 | 5146 | 1 |
6.410 | 226 | 2 |
6.420 | 28651 | 6 |
6.430 | 48407 | 12 |
6.440 | 2215 | 1 |
Last trade - 15.59pm 13/08/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online